UK opens AI Biosecurity Lab backed by £100M and up to £200M from OpenAI and Anthropic
The UK Cabinet Office announced the AI Biosecurity Lab on 24 October 2026 with £100M of public funding and up to £200M in credits from OpenAI and Anthropic.
By Emre AlemdarPublished
Tech AI LatestThe UK Cabinet Office announced the AI Biosecurity Lab on 24 October 2026, calling it the world's first dedicated AI biosecurity organisation. The government is putting in £100 million. OpenAI commits £100 million in compute and model credits, and Anthropic up to £100 million in model credits, both with trusted model access. Google DeepMind and Basecamp Research join as research partners. The lab will focus first on early detection of biological threats and faster vaccines and treatments.
Key facts
- Announced: 24 October 2026 (GOV.UK, Cabinet Office)
- Public funding: £100 million; company commitments: up to £200 million from OpenAI and Anthropic
- OpenAI: £100 million in compute and model credits plus trusted access through its Rosalind Biodefense programme
- Anthropic: up to £100 million in model credits, trusted model access and dedicated technical support
- Google DeepMind and Basecamp Research: research collaboration and model access; no figure stated
- Structure: independent non-profit under a National AI Biosecurity Initiative with UKHSA, APHA and Dstl
What the UK government announced
The UK Cabinet Office announced the AI Biosecurity Lab on 24 October 2026. The government describes it as the world's first dedicated AI biosecurity organisation, backed by up to £300 million in government funding and company commitments. The public share is £100 million. The lab will operate as an independent non-profit organisation and is launched as part of a National AI Biosecurity Initiative with the UK Health Security Agency, the Animal and Plant Health Agency and the Defence Science and Technology Laboratory.
The lab's job is to develop technical capabilities that help the UK understand, prevent, detect and respond to biological threats. Its initial focus is early detection of emerging biological threats and faster development of vaccines, treatments and other medical countermeasures. It will support national biosecurity centres and the life sciences industry, and it will work with the medicines regulator MHRA on health emergency preparedness and on the regulation of AI-designed medicines. A scientific advisory committee will be set up, with details to follow.
What each company commits
OpenAI commits £100 million in compute and model credits, plus trusted access to its most capable relevant models through its Rosalind Biodefense programme. Anthropic commits up to £100 million in model credits, trusted model access and dedicated technical support. Together these make up the £200 million in company commitments. Google DeepMind will run research collaborations with its scientists and biosecurity experts and intends to provide trusted access to Gemini and specialised science models; no monetary figure is given. Basecamp Research will provide access to its AI biology models and technical expertise, also without a stated figure.
The announcement names no spokespeople and gives no staff numbers, location or opening date for the lab. The terms of the trusted model access, which normally means fewer safety restrictions for vetted users, are not described.
Why it matters
This is a government body built around frontier model access rather than a regulation, and the money comes mostly from two AI companies in the form of credits rather than cash. That structure gives the lab capacity on day one but ties its work to the providers' models and their trusted access programmes. The announcement follows the UK's 12 October statement on using frontier AI for national cyber defence and fits the government's pattern of pairing model developers with national security agencies. It is the first time the UK has put a pound figure on biosecurity-specific AI work.
What to watch next
The open questions are who will lead the lab, where it will sit, when the scientific advisory committee is named, and how the £100 million of public money is phased, none of which the announcement states. The first measurable outputs should be detection tools delivered to UKHSA and APHA. Further UK and EU policy stories are listed under AI Policy & Regulation.
What changed
| Before | UK biosecurity work on AI sat inside existing agencies such as UKHSA, APHA and Dstl, with no dedicated AI biosecurity body or published funding |
|---|---|
| After | A new independent non-profit AI Biosecurity Lab with £100 million of public funding and up to £200 million in credits and model access from OpenAI and Anthropic |
| Who it affects | UK biosecurity agencies, life sciences companies, the AI providers supplying models, and the MHRA on AI-designed medicines |
Questions people ask
- How much funding does the UK AI Biosecurity Lab have?
- £100 million from the UK government plus up to £200 million in commitments from OpenAI and Anthropic, for a total of up to £300 million, according to the Cabinet Office announcement.
- What will the AI Biosecurity Lab do?
- Develop technical capabilities to detect and respond to biological threats, starting with early detection and faster development of vaccines and treatments, and support agencies such as UKHSA, APHA and Dstl.
- Is Google DeepMind funding the lab?
- The announcement says Google DeepMind will collaborate on research and intends to provide trusted access to Gemini and science models. No monetary figure is given.
Sources
- Introducing the AI Biosecurity Lab (GOV.UK (Cabinet Office), 24 Oct 2026)
Reference pages
- OpenAI company
- Anthropic company
- Google DeepMind company
Spotted an error? See the corrections policy and tell the editor. Facts in this story come from the sources listed above; vendor claims are attributed.
Comments
Loading comments.





